Market Size – USD 15.49 Billion in 2018, Market Growth - CAGR of 7.1%, Market Trends – The rising demand for bioresorbable vascular scaffolds
New York, NY -- (SBWIRE) -- 04/14/2021 -- The rise in geriatric population, bioresorbable vascular scaffolds, developments in interventional cardiology devices have resulted in boosting the Interventional Cardiology Devices market.
Market Size – USD 15.49 Billion in 2018, Market Growth - CAGR of 7.1%, Market Trends – The rising demand for bioresorbable vascular scaffolds
The global Interventional Cardiology Devices Market is forecast to reach USD 28.67 Billion by 2027, according to a new report by Reports and Data. Interventional cardiology can be defined as a branch of cardiology that focuses specifically on the treatment of structural heart diseases, based on catheters. It is contrary to noninvasive or preventive treatments such as lifestyle changes and most imaging techniques, wherein this method of treatment mainly deals with more invasive treatments, involving stenting and catheters. Previously open-heart surgery was considered as the only option for care users having narrowing aortic heart valve or at a high risk of aortic stenosis. The fact that this form of cardiovascular treatment is a non-surgical option has resulted in its growing popularity, which in turn is boosting the demand for interventional cardiology devices. Furthermore, growing geriatric population and developments in interventional cardiology devices are some of the factors further propelling the growth of the market.
In context to region, Europe can be seen to occupy a prominent market share. The increasing occurrence rate of lifestyle diseases, continuous growth in the geriatric population, and expansion of the healthcare sector are some of the factors supporting the growth of the market in this region.
Key participants include Abbott, Terumo Medical Corporation, Medtronic Inc., Boston Scientific Corporation, B Braun Melsungen, Johnson & Johnson, Ivascular, C. R. Bard, Terumo Corporation and Biotronik.
Get a sample of the report @ https://www.reportsanddata.com/sample-enquiry-form/2361
Further key findings from the report suggest
- The Interventional Cardiology Devices market held a market share of USD 15.49 Billion in the year 2018 that is forecasted to grow at a rate of 7.1% during the forecast period.
- In context to Product Type, the Stents segment generated the highest revenue of USD 8.52 Billion in the year 2018, with a growth rate of 7.4% during the forecast period. The extensive application of the cardiology devices in angioplasty procedures, wherein it is applied in more than 70% of these procedures, contributes to the revenue generated by this segment. A combination of stenting and angioplasty helps in enhancing the quality of life, particularly when performed after a heart attack, also contributes to its high acceptance and recommendation among care service providers.
- In context to Application, the Coronary angioplasty segment can be seen to generate the highest revenue of USD 4.34 Billion in 2018, with a growth rate of 7.3% during the forecast period. The high incidence rate of coronary artery diseases and applicability of angioplasty and associated devices in the treatment of the condition contributes to the revenue generated by this segment.
- In context to End-user, the Hospital segment is dominating that generated the highest revenue of USD 8.67 Billion in 2018, with a CAGR of 7.2% during the forecast period. The revenue generated by the segment is resultant of an increasing rate of hospitalization associated with cardiovascular diseases and elevated demand for interventional cardiology devices for providing treatment to these care users in hospitals.
To identify the key trends in the industry, click on the link below: https://www.reportsanddata.com/report-detail/interventional-cardiology-devices-market
For the purpose of this report, Reports and Data have segmented the global Interventional Cardiology Devices market according to Product Type, End-user, Application, and Region:
Product Type Outlook (Revenue, USD Billion; 2016-2027)
Intravascular Ultrasound (IVUS) Catheters
Stents
PTCA Guidewires
Balloon Inflation Device
PTCA Balloons
End-user Outlook (Revenue, USD Billion; 2016-2027)
Homecare Setting
Hospital
Ambulatory surgical centers
Clinic
Others
Application Outlook (Revenue, USD Billion; 2016-2027)
Coronary angioplasty
Congenital heart defect correction
Valvuloplasty
Percutaneous valve repair
Percutaneous valve replacement
Coronary thrombectomy
Others
Regional Outlook (Revenue, USD Billion; 2016-2027)
North America
Europe
Asia Pacific
MEA
Latin America
Request Customization of the report @ https://www.reportsanddata.com/request-customization-form/2361
Table of Content:
Chapter 1. Market Synopsis
1.1. Market Definition
1.2. Research Scope & Premise
1.3. Methodology
1.4. Market Estimation Technology
Chapter 2. Executive Summary
2.1. Summary Snapshot, 2018-2027
Chapter 3. Indicative Metrics
Chapter 4. Interventional Cardiology Devices Market Segmentation & Impact Analysis
4.1. Interventional Cardiology Devices Market Segmentation Analysis
4.2. Industrial Outlook
4.2.1. Market indicators analysis
4.2.2. Market drivers analysis
4.2.2.1. Developments in interventional cardiology devices
4.2.2.2. The rise in geriatric population
4.2.2.3. Bioresorbable Vascular Scaffolds
4.2.3. Market restraints analysis
4.2.3.1. Stringent regulations
4.3. Technological Insights
4.4. Regulatory Framework
4.5. ETOP Analysis
4.6. Porter's Five Forces Analysis
4.7. Competitive Metric Space Analysis
4.8. Price Trend Analysis
….
Chapter 9. Competitive Landscape
9.1. Market Revenue Share By Manufacturers
9.2. Manufacturing Cost Breakdown Analysis
9.3. Mergers & Acquisitions
9.4. Market positioning
9.5. Strategy Benchmarking
9.6. Vendor Landscape
Chapter 10. Company Profiles
10.1. Abbott
10.1.1. Company Overview
10.1.2. Financial Performance
10.1.3. Technology Insights
10.1.4. Strategic Initiatives
10.2. Terumo Medical Corporation
10.2.1. Company Overview
10.2.2. Financial Performance
10.2.3. Technology Insights
10.2.4. Strategic Initiatives
10.3. Medtronic Inc.
10.3.1. Company Overview
10.3.2. Financial Performance
10.3.3. Technology Insights
10.3.4. Strategic Initiatives
10.4. Boston Scientific Corporation
10.4.1. Company Overview
10.4.2. Financial Performance
10.4.3. Technology Insights
10.4.4. Strategic Initiatives
10.5. B Braun Melsungen
10.5.1. Company Overview
10.5.2. Financial Performance
10.5.3. Technology Insights
10.5.4. Strategic Initiatives
Continue….
Thank you for reading our report. For customization inquiry or further information, please connect with us and we will ensure you get the report that meets your requirements.
Browse More Related Reports :
Structural Electronics Market Outlook
Agricultural Biostimulants Market Revenue
Nitrobenzene Market Revenue
Cellulose Acetate Fiber Market Size
Methyl Ethyl Ketone Market Share
About Reports and Data
Reports and Data is a market research and consulting company that provides syndicated research reports, customized research reports, and consulting services. Our solutions purely focus on your purpose to locate, target and analyze consumer behavior shifts across demographics, across industries and help client's make a smarter business decision. We offer market intelligence studies ensuring relevant and fact-based research across a multiple industries including Healthcare, Technology, Chemicals, Types, and Energy. We consistently update our research offerings to ensure our clients are aware about the latest trends existent in the market.
Contact Us:
John W
Head of Business Development
Reports and Data | Web: www.reportsanddata.com
Direct Line: +1-212-710-1370
E-mail: sales@reportsanddata.com